The team


Management Team



Philippe Lluel, PhD - CEO

Philippe has more than 20 years of research and management positions in the pharmaceutical industry. He has extensive experience in drug discovery in urological field. He was involved in all aspects of drug development from discovery through registration. Philippe’s personal research interests have focused on the development of improved in vivo experimental models to facilitate the translation from preclinical to clinical studies. Philippe received his Ph.D. in Pharmacology from Pierre et Marie Curie University (Paris, France). He is the author of more than 25 peer-reviewed publications.
He is also the CEO of Urosphere.

Yolande Misseri, PhD, L.L.M. - CDO

Yolande has over 15 years of research and management positions in the biotech industry. She has extensive experience in drug discovery in the immuno-oncology field, intellectual property and business. She has been involved in drug development from discovery to clinical phases at BT PHARMA as project leader and at GENTICEL as Intellectual Property Director until 2016. She has then developed her expertise in strategic management of IP and alliances as a Consultant before joining UROLEAD end of 2018. Yolande’s personal interests are focused on the development of innovative preclinical solutions and new partnerships to facilitate the translation from preclinical to clinical studies. Yolande received her Ph.D. in Biology from the University of Montpellier II (Montpellier, France). She completed her scientific knowledge with a Master of Management of the Biotechnology at Toulouse Business School (Toulouse, France) and with a Master of Intellectual Property Law and Management at CEIPI (Strasbourg, France).


Scientific staff

Claire Beraud, PhD, Pharm. D

Project manager

Claire has over 10 years of research experience in the field of oncology. She had an initial education in pharmaceutical sciences in Toulouse (France). Then, she joined the Curie Institute (Paris, France) in 2004 and received her PhD degree in molecular and cellular biology 4 years later. Between 2009/2010, she worked as a post doc research scientist on renal cell carcinoma in Strasbourg (Inserm U682). She has developed and characterized Urolead PDX models since 2010.

Myriam Lassalle, Msc. Ing 

Project manager

Myriam has over 14 years of research experience in the field of oncology. With a Master of Engineering in biotechnology and a Clinical Research Associate Course, she firstly had a Research Engineer position at Theraptosis (Pasteur Institute, Paris) for 4 years, where she produced antibodies directed against cancer and analyzed their apoptotic potential on cancer cells. Then she acquired an extensive knowledge of in vivo PDX studies and of project management at XenTech, as a Study Director for 9 years. Then she joined Urosphere on September 2015, where she has been in charge of developing urogenital PDX models and of managing in vivo cancer studies. Since the acquisition of Urolead by Urosphere, Myriam has joined Urolead’s team.